Development, Analyze and Clinical Use of Tissue Engineering Large Diameter Autografts
Development, Analyze and Clinical Use of Tissue Engineering Large Diameter Autografts
批准号:
17591490
负责人:
YAMAMOTO Noboru
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
以犬下腔静脉为模型,对自体单核骨髓细胞(MN-BMC)和可生物降解支架构建的组织工程血管自体移植物(TEVA)进行了评价。MN-BMC取自犬下腔静脉,种植在由聚乙交酯纤维和聚(1-丙交酯-co-ε-己内酯)海绵组成的可生物降解管状支架上。手术当天,将该支架植入同一只狗的下腔静脉。植入后对TEVA进行生化、生物力学和组织学分析。当TEVA移植并在1个月时用乙酰胆碱刺激时,它们会产生剂量依赖性的硝酸盐和亚硝酸盐。N、G-硝基-L-精氨酸甲酯对上述反应有明显的抑制作用。在乙酰胆碱刺激下,第VIII因子阳性的Tevas细胞产生eNOS蛋白,而天然IVC、1月龄和3月龄Tevas的eNOS/S17mRNA比值相近。在植入后6个月,TEVA的生化特性和管壁厚度与天然IVC相似,对静脉压力的耐受性良好,无钙化等问题,说明TEVA是一种与功能内皮细胞和生物力学性能良好且无不良副作用的生物相容性材料。
英文摘要
This study demonstrates the evaluation of tissue-engineered vascular autografts (TEVAs) constructed with autologous mononuclear-bone marrow cells (MN-BMCs) and a biodegradable scaffold using a canine inferior vena cava (IVC) model.MN-BMCs were obtained from a dog and seeded onto a biodegradable tubular scaffold consisting of polyglycolide fiber and poly(1-lactide-co-ε-caprolactone) sponge. This scaffold was implanted in the IVC of the same dog on the day of surgery. TEVAs were analyzed biochemically, biomechanically and histologically after implantation. When TEVAs were explanted and stimulated with acetylcholine at 1 month, they dose dependently produced nitrates and nitrites. N^G-nitro-L-arginine methylester significantly inhibited these reactions. On the stimulation by acetylcholine, factor VIII-positive cells of TEVAs produced eNOS proteins, and the ratio of eNOS/s17 mRNA were similar among native IVC, 1-and 3-months TEVAs. TEVAs had similar biochemical properties and wall thickness as native IVC at 6 months after implantation, and tolerated venous pressure well without any problems such as calcification.These results indicate that TEVAs are biocompatible material with functional endothelial cells and biomechanical properties without unwanted side-effects.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
A successful total cavopulmonary connection conversion 13 years after anatomic repair for tricuspid atresia IIc with severe pulmonary resistance
具有严重肺阻力的三尖瓣闭锁 IIc 解剖修复术后 13 年成功完成全腔肺连接转换
DOI:
--
发表时间:
2005
期刊:
J Thorac Cardiovasc Surg 129
影响因子:
--
作者:
[Sugimoto K, Kurosawa H, Shin'oka T, Nagatsu M, Morishima S]
通讯作者:
Morishima S
Mid-term clinical results of tissue engineered vascular autografts seeded with autologous bome marrow cells
自体骨髓细胞接种组织工程自体血管移植物的中期临床结果
DOI:
--
发表时间:
2005
期刊:
J Thorac Cardiovasc Surg 129
影响因子:
--
作者:
[Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa]
通讯作者:
Kurosawa
培養人工血管-Tissue Engineering Graft-
培养人工血管-组织工程移植物-
DOI:
--
发表时间:
2006
期刊:
分子心血管病 7(5)
影响因子:
--
作者:
[Toshiki Watanabe, MD, Sadao Omata, PhD, Motoki Odamura, PhD, Masahumi Okada, Phd, Yoshihiko Nakamura, PhD, Hitoshi Yokoyama, MD, Matsumura Goki, 宮本 真嘉, 市原 有起, 保々 恭子]
通讯作者:
保々 恭子
Autopericardial patch tracheoplasty for tracheal stenosis after arterial switch operation
自体心包补片气管成形术治疗动脉调转术后气管狭窄
DOI:
--
发表时间:
2005
期刊:
J Card Surg 20
影响因子:
--
作者:
[Takiguchi M, Aoki M, Shin'oka T, Hiramatsu T, Imai Y]
通讯作者:
Imai Y
DOI:
10.1016/j.jtcvs.2004.10.030
发表时间:
2005-05-01
期刊:
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
影响因子:
6
作者:
[Hibino, N, Shin'oka, T, Kurosawa, H]
通讯作者:
Kurosawa, H
共 12 条
Tissue Engineered Vessels and Valve constructed with Autologous Bone Marrow Cells Its Clinical Applications and Evaluations
-
批准号:17390387
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.7万
-
财政年份:2005
-
负责人:YAMAMOTO Noboru
-
依托单位:
Activation Mechanism of Hepatocyte Growth Factor Sequestered in Extracellular matrix in liver
-
批准号:03670016
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1991
-
负责人:YAMAMOTO Noboru
-
依托单位:
海外基金